A Oneindia Venture

Audited Results of Glenmark Pharmaceuticals Ltd. Company

(Rs in Cr.) Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Operating Income 9,226.41 7,891.12 8,220.66 8,141.58 7,567.93
Manufacturing Expenses 148.32 137.73 83.22 76.87 66.83
Personnel Expenses 1,603.50 1,434.78 1,346.51 1,193.20 1,107.40
Selling Expenses 328.89 270.02 353.06 323.50 240.87
Administrative Expenses 1,633.26 1,508.40 1,497.76 1,334.13 1,227.72
Expenses Capitalised 0 0 0 0 0
Cost Of Sales 6,982.23 6,649.46 6,747.90 6,453.36 5,677.59
Operating Profit 2,244.18 1,241.66 1,472.77 1,688.22 1,890.34
Other Recurring Income 356.37 1,168.02 985.94 614.63 396.24
Adjusted PBDIT 2,600.55 2,409.69 2,458.71 2,302.85 2,286.58
Financial Expenses 48.73 277.11 206.82 236.04 265.90
Depreciation 218.63 202.16 184.15 159.69 150.81
Other Write offs 0 0 0 0 0
Adjusted PBT 2,333.18 1,930.41 2,067.74 1,907.11 1,869.87
Tax Charges 543.67 1,833.45 363.11 339.66 294.31
Adjusted PAT 1,789.52 96.96 1,704.64 1,567.46 1,575.56
Non Recurring Items -185.63 5,065.57 -495.24 431.94 76.38
Other Non Cash adjustments 0 0 0 0 0
Reported Net Profit 1,610.35 5,167.29 1,208.77 1,997.79 1,649.45
Equity Dividend 70.55 70.54 70.54 70.54 70.54
Preference Dividend 0 0 0 0 0
Retained Earnings 22,621.47 21,094.81 16,002.82 14,850.71 12,921.86

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+